The Food and Drug Administration (FDA) authorized emergency use of Regeneron's coronavirus antibody treatment on Saturday.
"The FDA remains committed to advancing the nation's public health during this unprecedented pandemic. Authorizing these monoclonal antibody therapies may help outpatients avoid hospitalization and alleviate the burden on our health care system," said FDA Commissioner Stephen M. Hahn.
Regeneron submitted an emergency use application for REGN-COV2 in October after preclinical studies showed the therapy reduced the virus and associated damage in the lungs of primates.
🔦 The treatment is the same that was given to President Trump when he contracted the virus in October.